Logo image of SOL

EMEREN GROUP LTD (SOL) Stock Fundamental Analysis

NYSE:SOL - New York Stock Exchange, Inc. - US75971T3014 - ADR - Currency: USD

1.23  -0.03 (-2.38%)

After market: 1.23 0 (0%)

Fundamental Rating

3

Overall SOL gets a fundamental rating of 3 out of 10. We evaluated SOL against 51 industry peers in the Construction & Engineering industry. SOL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SOL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SOL has reported negative net income.
In the past year SOL has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: SOL reported negative net income in multiple years.
In the past 5 years SOL always reported negative operating cash flow.
SOL Yearly Net Income VS EBIT VS OCF VS FCFSOL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

SOL's Return On Assets of -2.79% is on the low side compared to the rest of the industry. SOL is outperformed by 72.55% of its industry peers.
SOL has a Return On Equity of -4.15%. This is in the lower half of the industry: SOL underperforms 68.63% of its industry peers.
Industry RankSector Rank
ROA -2.79%
ROE -4.15%
ROIC N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
SOL Yearly ROA, ROE, ROICSOL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

With an excellent Gross Margin value of 26.20%, SOL belongs to the best of the industry, outperforming 80.39% of the companies in the same industry.
SOL's Gross Margin has declined in the last couple of years.
SOL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
SOL Yearly Profit, Operating, Gross MarginsSOL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

5

2. Health

2.1 Basic Checks

SOL does not have a ROIC to compare to the WACC, probably because it is not profitable.
SOL has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, SOL has more shares outstanding
SOL has a worse debt/assets ratio than last year.
SOL Yearly Shares OutstandingSOL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SOL Yearly Total Debt VS Total AssetsSOL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SOL has an Altman-Z score of -0.57. This is a bad value and indicates that SOL is not financially healthy and even has some risk of bankruptcy.
SOL's Altman-Z score of -0.57 is on the low side compared to the rest of the industry. SOL is outperformed by 88.24% of its industry peers.
SOL has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
SOL has a better Debt to Equity ratio (0.12) than 78.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z -0.57
ROIC/WACCN/A
WACC8.47%
SOL Yearly LT Debt VS Equity VS FCFSOL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

SOL has a Current Ratio of 3.87. This indicates that SOL is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SOL (3.87) is better than 100.00% of its industry peers.
A Quick Ratio of 3.87 indicates that SOL has no problem at all paying its short term obligations.
The Quick ratio of SOL (3.87) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.87
Quick Ratio 3.87
SOL Yearly Current Assets VS Current LiabilitesSOL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

SOL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.67%.
Looking at the last year, SOL shows a very negative growth in Revenue. The Revenue has decreased by -12.85% in the last year.
SOL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.02% yearly.
EPS 1Y (TTM)-16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.33%
Revenue 1Y (TTM)-12.85%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%-21.48%

3.2 Future

Based on estimates for the next years, SOL will show a very strong growth in Earnings Per Share. The EPS will grow by 72.80% on average per year.
SOL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.79% yearly.
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SOL Yearly Revenue VS EstimatesSOL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
SOL Yearly EPS VS EstimatesSOL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SOL. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 34.79 indicates a quite expensive valuation of SOL.
Based on the Price/Forward Earnings ratio, SOL is valued a bit more expensive than the industry average as 60.78% of the companies are valued more cheaply.
SOL's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.85.
Industry RankSector Rank
PE N/A
Fwd PE 34.79
SOL Price Earnings VS Forward Price EarningsSOL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

SOL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SOL is cheaper than 84.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.06
SOL Per share dataSOL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SOL's earnings are expected to grow with 72.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.8%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SOL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMEREN GROUP LTD

NYSE:SOL (4/21/2025, 8:04:00 PM)

After market: 1.23 0 (0%)

1.23

-0.03 (-2.38%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)03-13 2025-03-13/amc
Earnings (Next)05-21 2025-05-21/amc
Inst Owners45.15%
Inst Owner Change-0.03%
Ins Owners1.06%
Ins Owner Change0%
Market Cap63.13M
Analysts80
Price Target4.59 (273.17%)
Short Float %18.26%
Short Ratio3.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-190.92%
Min EPS beat(2)-384.65%
Max EPS beat(2)2.81%
EPS beat(4)1
Avg EPS beat(4)-157.93%
Min EPS beat(4)-384.65%
Max EPS beat(4)2.81%
EPS beat(8)2
Avg EPS beat(8)-862%
EPS beat(12)4
Avg EPS beat(12)-563.39%
EPS beat(16)6
Avg EPS beat(16)-421.24%
Revenue beat(2)0
Avg Revenue beat(2)-33.12%
Min Revenue beat(2)-51.47%
Max Revenue beat(2)-14.76%
Revenue beat(4)2
Avg Revenue beat(4)-6.26%
Min Revenue beat(4)-51.47%
Max Revenue beat(4)41.07%
Revenue beat(8)2
Avg Revenue beat(8)-19.67%
Revenue beat(12)3
Avg Revenue beat(12)-26.09%
Revenue beat(16)4
Avg Revenue beat(16)-21.2%
PT rev (1m)-10%
PT rev (3m)-15.62%
EPS NQ rev (1m)-200%
EPS NQ rev (3m)-100%
EPS NY rev (1m)-90.28%
EPS NY rev (3m)-89.6%
Revenue NQ rev (1m)-27.56%
Revenue NQ rev (3m)-26.98%
Revenue NY rev (1m)-41.78%
Revenue NY rev (3m)-41.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 34.79
P/S 0.69
P/FCF N/A
P/OCF N/A
P/B 0.21
P/tB 0.21
EV/EBITDA 9.06
EPS(TTM)-0.21
EYN/A
EPS(NY)0.04
Fwd EY2.87%
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS1.79
BVpS5.86
TBVpS5.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.79%
ROE -4.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.2%
FCFM N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA 5.81
Cap/Depr 227.72%
Cap/Sales 17.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.87
Quick Ratio 3.87
Altman-Z -0.57
F-Score3
WACC8.47%
ROIC/WACCN/A
Cap/Depr(3y)305.97%
Cap/Depr(5y)240.17%
Cap/Sales(3y)29.54%
Cap/Sales(5y)22.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.33%
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.85%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%-21.48%
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y92.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y41.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.72%
OCF growth 3YN/A
OCF growth 5YN/A